Clinical trial
Intrathecal Fentanyl Versus Intravenous Granisetron for the Prevention of Perioperative Nausea and Vomiting During Cesarean Delivery Under Spinal Anesthesia
NCT05474001 is registered in ClinicalTrials.gov with Mohamed Youssef Mohamed as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intrathecal Fentanyl Versus Intravenous Granisetron for the Prevention of Perioperative Nausea and Vomiting During Cesarean Delivery Under Spinal Anesthesia
- Lead sponsor
- Mohamed Youssef Mohamed
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 1, 2022
- Completion date
- January 30, 2024
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nausea and vomiting, postoperative